First author (year)
Number of patients
Cardiac Manifestations
Troponin
In-Hospital Mortality
SARS-CoV
Lee (2003) 39 138 Acute HF (1pt) None 3.6%
Booth (2003) 40
144
Pulse>100bpm (46%) Chest pain (10.4%)
ND
6.5%
Li (2003) 23
46
RBBB 15.2% LVEF-HF 1pt (EF 30.2%) Initial TTE compare with 30 days control: Lower LVEF Lower Doppler-derived CO
ND
13%
Yu (2003) 7
121
Tachycardia (71.9%) Hypotension (50.4%) Bradycardia (14.9%) Rev cardiomegaly (10.7%)
ND
ND
MERS-CoV Saad (2014) 13 70 Arrythmias (15.7%) ND 60%
Al-Tawfiq (2014) 41
17
X-ray cardiomegaly (53%) Chest pain (7%)
ND
76%
Assiri (2016) 43 47 Chest pain (15%) ND 60%
Al-Albdallat (2014) 14
9
Chest pain (44%) Pericarditis (1 pt) VT (1 pt) SVT (1 pt)
ND
22%
H1N1 Influenza Schoen (2019) 42 160 Chest pain (5%) ND Zero
SARS-CoV-2
Huang (2020) 20
41
Shock (7%)
Elevated in 12.2%
15%
Wang (2020) 2
118
Arrhythmia (16.7%) Shock (8.7%) Acute cardiac injury (7.2%)
Mean 6.4 pg/ml
4.3%
Shi (2020) 1
416
Chest pain (3.4%) ST-depression ECG (0.7%)
Elevated in 19.7%
13.7%
Zhou (2020) 22
191
Heart Failure (23%) Hypotension (1%) HR>125bpm (1%) Elevated in 17%
28.2%
Guo (2020) 21 187 VT/VF (5.9%) Elevated in 27.8% 23%